Frequency of Opioid Use in a Population of Cancer Patients During the Trajectory of the Disease

Clinical Oncology

Volumn 22, Issue 3, 2010, Pages 199-207

  Jarlbaek, L ^a,b   Hansen, D G ^a   Bruera, E ^c   Andersen, M ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer patients; Cohort study; Disease duration; Opioids; Pain treatment; Pharmaco epidemiology

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TIME OF DEATH;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN;

EID: 77950032432     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.12.002     Document Type: Article

References (37)

1. Vuorinen E. Pain as an early symptom in cancer. Clin J Pain 1993, 9(4):272-278.
2. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., Schouten H.C., van K.M., Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007, 18(9):1437-1449.
3. Davis M.P., Walsh D. Epidemiology of cancer pain and factors influencing poor pain control. Am J Hosp Palliat Care 2004, 21(2):137-142.
4. Deandrea S., Montanari M., Moja L., Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008, 19(12):1985-1991.
5. World Health Organization Achieving balance in national opioids control policy Available from:. http://www.who.int.
6. Agency for Healthcare Research and Quality Management of cancer pain. summary, evidence report/technology assessment: Number 35. AHRQ Publication No. 01-E033 2001, Agency for Healthcare Research and Quality, Rockville, MD, Available from:. http://www.ahrq.gov/clinic/epcsums/canpainsum.htm.
7. Jost L., Roila F. Management of cancer pain: ESMO clinical recommendations. Ann Oncol 2008, 19(Suppl. 2):ii119-ii121.
8. Hamunen K., Laitinen-Parkkonen P., Paakkari P., et al. What do different databases tell about the use of opioids in seven European countries in 2002?. Eur J Pain 2008, 12(6):705-715.
9. World Health Organization Cancer pain relief. With a guide to opioid availability 1996, World Health Organization, Geneva. 2nd edn.
10. Blengini C., Joranson D.E., Ryan K.M. Italy reforms national policy for cancer pain relief and opioids. Eur J Cancer Care (Engl) 2003, 12(1):28-34.
11. Sorensen H.T., Sabroe S., Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 1996, 25(2):435-442.
12. Danish National Board of Health, The Cancer Registry New figures from The National Board of Health [Cancerregisteret 1997. Nye tal fra Sundhedsstyrelsen. Aargang 5. nr. 5 2001] Available from:. http://www.%20sst%20dk/nyheder/tidsskrifter/nyetal/pdf/nyetal5_5%20pdf%202002.
13. Storm H.H., Michelsen E.V., Clemmensen I.H., Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997, 44(5):535-539.
14. Gaist D., Sorensen H.T., Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44(4):445-448.
15. Jarlbaek L., Andersen M., Kragstrup J., Hallas J. Cancer patients' share in a population's use of opioids. A linkage study between a prescription database and the Danish Cancer Registry. J Pain Symptom Manage 2004, 27(1):36-43.
16. Jarlbaek L., Andersen M., Hallas J., Engholm G., Kragstrup J. Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage 2005, 29(4):336-343.
17. Hallas J. Conducting pharmacoepidemiologic research in Denmark. Pharmacoepidemiol Drug Saf 2001, 10(7):619-623.
18. World Health Organization, Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment 2002 2002, World Health Organization, Geneva. 5th edn.
19. Mercadante S., Casuccio A., Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000, 20(2):104-112.
20. Schuit K.W., Sleijfer D.T., Meijler W.J., et al. Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage 1998, 16(5):290-297.
21. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., Schouten H.C., van K.M., Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain 2007, 132(3):312-320.
22. Sykes N., Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 2003, 4(5):312-318.
23. Larue F., Colleau S.M., Brasseur L., Cleeland C.S. Multicentre study of cancer pain and its treatment in France. Br Med J 1995, 310(6986):1034-1037.
24. Niscola P., Cartoni C., Romani C., et al. Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey. Ann Hematol 2007, 86(9):671-676.
25. Torvik K., Holen J., Kaasa S., et al. Pain in elderly hospitalized cancer patients with bone metastases in Norway. Int J Palliat Nurs 2008, 14(5):238-245.
26. Rose J.H., O'Toole E.E., Einstadter D., Love T.E., Shenko C.A., Dawson N.V. Patient age, well-being, perspectives, and care practices in the early treatment phase for late-stage cancer. J Gerontol A Biol Sci Med Sci 2008, 63(9):960-968.
27. Pergolizzi J., Boger R.H., Budd K., et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008, 8(4):287-313.
28. Delgado-Guay M.O., Bruera E. Management of pain in the older person with cancer. Oncology (Williston Park) 2008, 22(1):56-61.
29. Sjogren P., Banning A.M., Jensen N.H., Jensen M., Klee M., Vainio A. Management of cancer pain in Denmark: a nationwide questionnaire survey. Pain 1996, 64(3):519-525.
30. Froelund F., Jensen N.-H. The use of opioids in Denmark [Opioidforbruget i Danmark]. Maanedsskr Prakt Laegegern 1995, 73:1529-1533.
31. Vainio A. Use of morphine and other opioids in the Nordic countries. Acta Oncol 1998, 37(7-8):743-748.
32. INCB Narcotic drugs, table IX, X, XI Available from:. http://www.incb.org/e/ind_tr.htm.
33. Danish Medicines Agency [Lægemiddelstyrelsen] The use of opioids in the primary care sector. Denmark 1999-2003 Available from:. http://www.laegemiddelstyrelsen.dk/publikationer/netpub/forbrugsanalyser/opioid/.
34. Jarlbaek L., Hallas J., Kragstrup J., Andersen M. Cancer patients' first treatment episode with opioids: a pharmaco-epidemiological perspective. Support Care Cancer 2006, 14(4):340-347.
35. Schneeweiss S., Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005, 58(4):323-337.
36. Cousins M.J., Brennan F., Carr D.B. Pain relief: a universal human right. Pain 2004, 112(1-2):1-4.
37. Joranson D.E. Improving availability of opioid pain medications: testing the principle of balance in latin America. J Palliat Med 2004, 7(1):105-114.